chrisvoncsefalvay/vaers-outcomes huggingface dataset:
elevated WBC; sore throat when she swallows; fever; rash; sores on her lip; This spontaneous case was reported by a patient and describes the occurrence of RASH (rash), WHITE BLOOD CELL COUNT INCREASED (elevated WBC), LIP PAIN (sores on her lip), PYREXIA (fever) and OROPHARYNGEAL PAIN (sore throat when she swallows) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced RASH (rash) and LIP PAIN (sores on her lip). On 01-Apr-2021, the patient experienced PYREXIA (fever). On 03-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat when she swallows). On 06-Apr-2021, the patient experienced WHITE BLOOD CELL COUNT INCREASED (elevated WBC). At the time of the report, RASH (rash), WHITE BLOOD CELL COUNT INCREASED (elevated WBC), LIP PAIN (sores on her lip), PYREXIA (fever) and OROPHARYNGEAL PAIN (sore throat when she swallows) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. Caller stated the was prescribed antibiotics on 12APR2021, which have not been started.
Blood clot in right calf and lungs. Blood thinners were given to dissolve the blood clots while hospitalized. Blood clot in the leg has not gone away and I continue to take Eliquis.  Doppler Ultrasound performed on 6/21/2021 at doctors office and instructed to continue taking Eliquis for 3-6 months.  I was on vacation at the time of receiving vaccine and hospitalization for blood clots, I have since returned home.
This spontaneous report as received from a Health care worker pharmacy technician refers to a unspecified number of patients of unknown age and gender. On an unknown dates the patients were vaccinated with ROTATEQ lot # J008739 exp 25-MAR-2015, oral (dose not provided), ROTATEQ lot # J012525 exp 09-APR-2015, oral (dose not provided), ROTATEQ lot # J18367 exp 02-APR-2015, oral (dose not provided) and ROTATEQ lot # J004875 exp 17-OCT-2014, oral (dose not provided). Health care worker (pharmacy technician) stated than an unspecified number of patients may have received vaccines (doses and dose in series unspecified) that were improperly stored on 28-FEB-2014 at 9.5 C for 50 minutes. No adverse effects reported. The outcome of incorrect product storage was unknown. This is one of several reports from same source. Additional information has been requested.
Developed Angioedema/hives on leg about 60 hours after 2nd vaccine and severe Angiodema on face/lips about 85 hours after 2nd vaccine
Fever, wheezing. Given Childrens Motrin and kept eye on him and called and went to his dr. office first thing that monday morning.
This case was reported by a healthcare professional (nurse practitioner) and described the occurrence of low grade fever in a 59-year-old male subject who was vaccinated with FLUARIX (GlaxoSmithKline). Concurrent medical conditions included hypertension. Concurrent medications included BENICAR, Aspirin and Cholesterol reducing agent. On 25 October 2011 the subject received a dose of FLUARIX (.5 ml, unknown route). In 2011, less than one month after vaccination with FLUARIX "sometime before 15 November 2011", the subject experienced low grade fever, diffuse muscular pain, nausea, chest pain "substernal", flu like symptoms, musculoskeletal strain and viral infection. The subject denied worsening of chest pain during exercise or meals. The subject sought treatment at a medical institution and was treated with VICODIN and ibuprofen. The symptoms persisted and the subject sought treatment at the emergency department at the institution of the reporter. The subject was diagnosed with chest pain secondary to musculoskeletal strain secondary to a viral infection. The subject was hospitalised. The subject was discharged on 18 November 2011. On 16 November 2011, the events were resolved (48 hours prior to the hospital discharge). This is two of two cases from this healthcare professional. The first case involves events with FLULAVAL. See A0959900A for details regarding the first case.
Patient became very cranky had 8 episodes of vomiting and 1 bout of loose stool.  Reported temp of 100.0.  After approximately 2 hrs was back to normal self.
Site swelling, red, hot to touch, headache, joint pain, chills onset same day. Upper arm rash Day 2 Rash spread Day 3- Day 10 upper arm to right chest then spread to chest up to neck around to the back of the neck.  Next spread down the chest to torso and to other upper arm. Day 11 spread to right and left lower arms.
Received second Moderna vaccine on 2/22/2021 followed  the following day by fever over 100, headache, aches, generally ill feeling. Reoccurance of genital herpes about March 7, 2021  after not having  had an outbreak in about 30 years; acylovair  was prescribed by doctor and outbreak ended in about 7 days   (Previously had Covid Jan 2020)
About 2 hrs after vaccination, child refused to walk complaining of pain in leg.  Given Ibuprophen and no relief and continued to refuse to walk.  Slept through night and woke up and continues to refuse to walk complaining of pain in Left thigh.  Pain is worse when bending over and bearing weight.   Mother brought child back to clinic on 8/22, observed her difficulty walking.  No swelling or redness present at site.  Both legs are similar in size.  Pedal pulses present and no discoloration of skin.  Child denies radiating pain and is only localized to site of injection. Instructed mother to continue to monitor ambulation.  To rest leg today and continue to offer pain meds as needed.  To f/u with MD if s/s worsen or do not improve after 48hrs.
Headache, NauseaVomiting, Fatigue, Redness and swelling to right arm Narrative:  Other Relevant History:
Discuss adverse effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Discuss adverse effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Discuss adverse effects). At the time of the report, VACCINATION COMPLICATION (Discuss adverse effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment medication was not reported.
Pain, / in the arm (site of injection); swollen / in the arm (site of injection); redness in the arm (site of injection); general discomfort.; This case was reported by a nurse via sales rep and described the occurrence of injection site pain in a patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero. On an unknown date, unknown after receiving Bexsero, the patient experienced injection site pain, injection site swelling, injection site erythema and general discomfort. On an unknown date, the outcome of the injection site pain, injection site swelling, injection site erythema and general discomfort were unknown.   It was unknown if the reporter considered the injection site pain, injection site swelling, injection site erythema and general discomfort to be related to Bexsero.  Additional details were reported as follows: The age at vaccination was not reported. Nurse informed that after the vaccination of patient with Bexsero, the patient experienced pain, swollen, redness in the arm (site of injection) and general discomfort. The reporter consented to follow up. This case is 1 of the 13 cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR209822:same reporter US-GLAXOSMITHKLINE-US2020AMR210159:same reporter US-GLAXOSMITHKLINE-US2020AMR210162:same reporter US-GLAXOSMITHKLINE-US2020AMR210157:same reporter US-GLAXOSMITHKLINE-US2020AMR210163:same reporter US-GLAXOSMITHKLINE-US2020AMR210158:same reporter US-GLAXOSMITHKLINE-US2020AMR210161:same reporter US-GLAXOSMITHKLINE-US2020AMR210160:same reporter US-GLAXOSMITHKLINE-US2020208660:same reporter US-GLAXOSMITHKLINE-US2020AMR210165:same reporter US-GLAXOSMITHKLINE-US2020AMR210166:same reporter US-GLAXOSMITHKLINE-US2020AMR210156:same reporter
Raised welt at injection site - Bright red with pain, swelling, and very warm to the touch.
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date) and NO ADVERSE EVENT (no adverse event) in a 54-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7172B) for COVID-19 prophylaxis.     Concurrent medical conditions included Immunocompromised.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date).    No concomitant medications were reported.  The vial was initially stored in the refrigerator on 29-Dec-2022  The vial did not undergo any temperature excursions.  BUD was reported as 28-Jan-2023.  No treatment medications were reported.
20min p/vax pt devel light red color on forearm which resembled a sunburn;began feeling very shaky & dizzy & nauseated;pt was given DPH;BP 110/60, P86;no breathing diff;rash spread to rt arm about 20mins p/appeared on lt arm;slept 2 days
patient called saying she had "covid arm" described it as a itchy rash that presented about 7 days after vaccination. She started using OTC hydrocortisone Crm and oral 25mg otc Benadryl.
About 17-19 hours after I received my Moderna booster I developed chills, mild fever, soreness in injection location of left shoulder, followed by my left armpit being very swollen and body aches.  It also felt like I could have diarrhea, but it was just regular bowels.
Received vaccines 2/4/14. On 2/21/14 developed rash on face (R) UE, trunk, legs. C/O itching, erythema. No heat. Taking BENADRYL 1.25 mg, applying Cortizone cream. Taking oatmeal baths to relieve pruritis.
Swelling, erythema, rest, ice. Pain (L) upper extremity elevation. Pain meds, AUGMENTIN 875-125 bid 10 days.
104 fever, hyper salivation, couldn't swallow, choking, dehydration.
101 fever; chills;aches menstruation started day after fever subsided, 2 weeks early
illness/could not go to work; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (illness/could not go to work) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (illness/could not go to work). At the time of the report, ILLNESS (illness/could not go to work) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.
This spontaneous report was received from a healthcare worker refers to an unspecified patients of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored ROTATEQ, (lot #, dose and frequency were unknown). No adverse effects reported. The outcome of the events was unknown. No product quality complaint (PQC) was involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
pt recvd vax in AUG92 & FEB93 & on 2MAR93 pt devel blindness in rt eye; pt was adm to hosp; MRI & MS screen were neg; dx of optic neuritis was made;
Received DTaP 12/31/02 noticed reaction evening of 12/31 - called ER. On 1/1/03 was told it was a normal reaction. Child's arm red, hot from shoulder to elbow. Called MD 1/2/03, advised to have area checked by PCP. PCP office called and vaccine adverse event report filled out.
lethargy; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LETHARGY (lethargy). At the time of the report, LETHARGY (lethargy) outcome was unknown.            No concomitants or treatment medications were reported.
Symptoms started night of injection (4/10) with not feeling well, no fever was noted.  Both my husband and I woke in the middle of night with arms hurting.  Took Advil, which helped.    Then morning of 4/11/21, have fever - 100.9 in right ear and 100.7 in left ear.  Swimmy head, but no headache.  At the time of this entry, still have fever.  Fever keep going up.
Rash at site of injection with spread to whole body. Fever X 24 hrs.
Tested positive for Covid on 5/10. Experienced splitting headaches, and nauseous and fatigue and loss of appetite persist even with PAXLOVID.
Pfizer COVID 19 EUA; left arm tingling (for about 1 hour), difficulty breathing and tongue and lips tingling (for about 2 hours) all with occurred within 4 hours of getting vaccine
She came Wednesday (11-4-15) for PREVAR 13 (reconstituted) by her dr.) and by Friday she started having swelling redness and itching, she came to the pharmacy to check the site of injection and she was referred to the dr. Today (11-11-15) she come with rx for SEPTRA DS and hydroxyzine tabs.
At approximately 1105, patient was vaccinated and immediately fainted in vaccination chair. Patient slumped over in chair for approximately 15 seconds and vaccinator held patient in chair. Patient was alert and oriented to person, place, time, and situation. At 1120, EMT assessed patient vitals: blood pressure 132/86 mmHg, pulse 94 beats/minute, and respirations 18 breaths/minute. Patient reported a headache and history of fainting when feeling nervous. Patient given water and assisted to cot to lay down. At 1135, patient vitals reassessed: blood pressure 128/56 mmHg, pulse 59 beats/minute, and respirations 13 breaths/minute. Patient reported his headache was "going away". At 1200, patient vitals reassessed: blood pressure 122/76 mmHg, pulse 61 beats/minute, and respirations 12 breaths/minute. Patient stated he felt "good". Lead nurse educated patient on signs/symptoms of when to seek emergency care, to sign up on CDC site, and to follow up with primary care provider. At 1201, patient left facility with steady gait and unlabored respirations.
Patient experience dizziness later in the day after vaccinated. Stopped. Rash around site later in day after vaccination, then disappeared. Patient reported arm swelled from elbow on up. Red around site. Site hard. Applied ice and took TYLENOL and Ibuprofen. Improving.
Egregious fatigue, muscle aches. Symptoms have not abated, they are ongoing.
Headache, shaking chills, body aches, fever up to 103.7, fatigue
75-year-old male presenting with speech changes.  Patient accompanied by need he reports that he  was last seen normal between 11 and 12:00 a.m..  Patient went to get his COVID vaccine and then to  the grocery store.  He drove home and pulled into the garage but when he did not get out of the car  his neighbor went to check on him.  His neighbor states  patient was awake but aphasic and  paralyzed on the right side.  He moved into the passenger seat and drove directly to the hospital.   Patient started to talk and had difficulty expressing words.  Patient denies headache, chest pain  shortness of breath, nausea orvomiting, abdominal pain or diarrhea. Neighbor states patient has a history of a bleeding stroke 2 years It was a bleed into the outside of the brain on the left side of head as a result of a hall that caused problems for me.
On 16 April 21, I experienced a transient event where I could not pick up a utensil from a drawer.  This event lasted about 5-10 seconds.  On 17 April 21, I went to the Hospital ER and they performed several tests including a CAT scan but was discharged with no conclusive diagnosis.  On 19 April 21, I returned to the ER and they called a stroke code.  After comparing the CAT scans, they confirmed I had a stroke.  On 22 Apr 2021, I was discharged. On 7 June 21, I again experienced the inability to use my right hand to pick up a utensil and my husband noticed slurred words.  My husband called 911 and I was admitted to Hospital and they confirmed I had another stroke.  After 4 days at Hospital with no diagnosis on why I was having these strokes, I was transferred to  Hospital.  After many tests, I was diagnosed with a brain aneurysm, endocarditis, and a heart murmur due to a damaged mitral valve.  On 21 Jun 2021, I was transferred to Medical Center to have brain aneurysm repaired.  I was discharged on 26 Jun 21.  Although the is no 100% proof the Moderna Vaccine caused these events, I was healthly with no pre-existing conditions prior to these events.  However, I thought these events should be reported through the proper VAERS site.
First Lot 025L20A Moderna Reactions Head ache, lips swelling. Diarrhea, stomach issues, dizzy, fatigue, chills in feet and hands. Second one Headache, nausea, fatigue, body aches, joint pain. Vaccine site real sore.
I have not had period bleeding for almost 18 months due to a uterine ablation (08/2012) and pre-menopause.  I had a period with a heavier than normal flow beginning January 27, 2021 - 22 days after the injection.
c/o tongue feeling thick and sinking in back of throat, trouble swallowing, chest started feeling tight. BP 116/76, P-72, R18. Administered Adult Epi Pen and Benadryl 50 mg IM. Transported to ER via EMS. Patient stable upon arrival ER, no additional meds given. D/C'd home.
No other adverse effects were reported; a patient received an expired dose of VAQTA; This spontaneous report has been received from a medical assistant regarding a patient of unknown age and gender. The patient's concurrent conditions, historical conditions and concomitant medications were not reported.   On 20-JUL-2020, the patient was vaccinated with an expired dose of Hepatitis A Vaccine, inactivated (VAQTA) 25/0.5 (units not reported) 0.5 milliliter, lot # S021092, expiration date 18-MAY-2020 as prophylaxis (route of administration not reported). No other adverse effects were reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; devicelotnumber: S021092; expirationdate: 18-MAY-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Localized swelling at injection site, the size of a tennis ball. C/O redness, itching, hot to the touch. Used BENADRYL and cool compresses. Swelling x 5 days.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Mar2021 as dose 1, single (Lot number: Er2614), in right arm, on 13Apr2021 as dose 2, single (Lot number: Ew0162), in left arm and on 13Oct2021 as dose 3 (booster), single (Lot number: Ff2593) at the age of 43 years, in left arm for covid-19 immunisation; elasomeran (COVID-19 VACCINE MODERNA), on 09Sep2022 as dose 4 (booster), single (Lot number: As7140C), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hashimoto's" (unspecified if ongoing), notes: Hashimoto's; "thyroid cancer" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID, start date: 01Jan2019. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: After completing 5 days of  paxlovid and testing negative for two days; Positive, notes: I am testing positive again. Therapeutic measures  (PAXLOVID) were taken as a result of drug ineffective, covid-19.